EPAM
GSK icon

Euro Pacific Asset Management’s GSK GSK Stock Holding History

Euro Pacific Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.59M Sell
206,634
-1,620
-0.8% -$85.7K 0.75% 32
2026
Q1 		$10.1M Sell
208,254
-2,559
-1% -$139K 1% 29
2025
Q4 		$9.44M Sell
210,813
-1,205
-0.6% -$56.2K 1.05% 27
2025
Q3 		$8.74M Sell
212,018
-1,243
-0.6% -$48.6K 1.06% 27
2025
Q2 		$8.2M Buy
213,261
+292
+0.1% +$11.2K 1.32% 25
2025
Q1 		$8.23M Sell
212,969
-1,196
-0.6% -$43.8K 1.49% 23
2024
Q4 		$7.22M Sell
214,165
-3,721
-2% -$134K 1.56% 26
2024
Q3 		$8.88M Sell
217,886
-3,336
-2% -$136K 1.64% 26
2024
Q2 		$8.55M Sell
221,222
-6,567
-3% -$276K 1.69% 26
2024
Q1 		$9.58M Sell
227,789
-6,327
-3% -$261K 1.95% 23
2023
Q4 		$8.74M Buy
234,116
+2,070
+0.9% +$74.3K 1.87% 26
2023
Q3 		$8.43M Sell
232,046
-1,664
-0.7% -$59.1K 1.97% 24
2023
Q2 		$8.17M Buy
233,710
+9,553
+4% +$343K 1.79% 26
2023
Q1 		$7.98M Buy
224,157
+1,302
+0.6% +$45.6K 1.71% 28
2022
Q4 		$7.76M Buy
222,855
+845
+0.4% +$28.1K 1.74% 27
2022
Q3 		$6.61M Buy
222,010
+15,944
+8% +$604K 1.74% 29
2022
Q2 		$11.1M Buy
206,066
+3,232
+2% +$178K 2.62% 16
2022
Q1 		$11.1M Buy
202,834
+17,052
+9% +$926K 2.17% 25
2021
Q4 		$10.2M Buy
185,782
+1,599
+0.9% +$83.2K 2.29% 22
2021
Q3 		$9.44M Buy
184,183
+15,727
+9% +$790K 2.46% 18
2021
Q2 		$8.38M Buy
168,456
+5,537
+3% +$266K 2.04% 23
2021
Q1 		$7.34M Buy
162,919
+7,209
+5% +$327K 1.89% 25
2020
Q4 		$7.26M Buy
155,710
+1,054
+0.7% +$48.4K 1.76% 25
2020
Q3 		$7.33M Sell
154,656
-546
-0.4% -$27.4K 1.86% 20
2020
Q2 		$7.96M Sell
155,202
-2,668
-2% -$137K 2.22% 19
2020
Q1 		$8.28M Sell
157,870
-120,721
-43% -$6.44M 2.74% 13
2019
Q4 		$16.4M Buy
+278,591
New +$15.5M 5.91% 3

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Euro Pacific Asset Management's GSK Position: Q2 2026 in Review

Euro Pacific Asset Management reduced its GSK (GSK) stake by 0.78% in Q2 2026, selling an estimated $85.7K and leaving 206,634 shares worth $6.59M. The position accounts for 0.75% of the portfolio, ranked #32.

Euro Pacific Asset Management first reported a position in GSK in Q4 2019 and has held it in 27 quarters since. The position peaked at $16.4M in Q4 2019. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Euro Pacific Asset Management held 206,634 shares of GSK worth $6.59M as of Q2 2026.
  • Euro Pacific Asset Management sold 1,620 GSK shares in Q2 2026, an estimated $85.7K.
  • GSK made up 0.75% of Euro Pacific Asset Management's portfolio in Q2 2026, its #32 holding.
  • Euro Pacific Asset Management first reported a position in GSK in Q4 2019 and has held it in 27 quarters since.
  • Euro Pacific Asset Management's GSK position peaked at $16.4M in Q4 2019.
  • 1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Euro Pacific Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.